✦ LIBER ✦

1665 BACILLUS CALMETTE-GUERIN ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER

✍ Scribed by Brausi, Maurizio; Oddens, Jorg; Sylvester, Richard; Bono, Aldo; van de Beek, Cees; van Andel, George; Gontero, Paolo; Hoeltl, Wolfgang; Turkeri, Levent; Collette, Sandra; Oosterlinck, Willem

Book ID: 122947225
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 49 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.1523

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1050 Bacillus Calmette-Guerin: One third

1050 Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer

✍ Brausi, M.A.; Oddens, J.R.; Sylvester, R.J.; Bono, A.V.; Van De Beek, C.; Van An 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 17 KB

Re: Final Results of an EORTC-GU Cancers

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-Third Dose versus Full Dose and 1 Year versus 3 Years of Maintenance

✍ Wood, David P. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

Re: Final Results of an EORTC-GU Cancers

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

✍ Inman, Brant A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Re: Final Results of an EORTC-GU Cancers

✍ Solsona, Eduardo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB